137 related articles for article (PubMed ID: 38393915)
1. Effects of Intranasal Dantrolene Nanoparticles on Brain Concentration and Behavior in PS19 Tau Transgenic Mice.
Vera R; Hong N; Jiang B; Liang G; Eckenhoff MF; Kincaid HJ; Browne V; Chellaraj V; Gisewhite D; Greenberg M; Ranjan S; Zhu G; Wei H
J Alzheimers Dis; 2024; 98(2):549-562. PubMed ID: 38393915
[TBL] [Abstract][Full Text] [Related]
2. Effects of intranasal dantrolene nanoparticles on brain concentration and behavior in PS19 tau transgenic mice.
Vera R; Hong N; Jiang B; Liang G; Eckenhoff MF; Kincaid HJ; Browne V; Chellaraj V; Gisewhite D; Greenberg M; Ranjan S; Zhu G; Wei H
Res Sq; 2023 May; ():. PubMed ID: 37214948
[TBL] [Abstract][Full Text] [Related]
3. Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice.
Shi Y; Zhang L; Gao X; Zhang J; Ben Abou M; Liang G; Meng Q; Hepner A; Eckenhoff MF; Wei H
J Alzheimers Dis; 2020; 76(4):1375-1389. PubMed ID: 32623395
[TBL] [Abstract][Full Text] [Related]
4. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
[TBL] [Abstract][Full Text] [Related]
5. Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathy.
Ou W; Yang J; Simanauskaite J; Choi M; Castellanos DM; Chang R; Sun J; Jagadeesan N; Parfitt KD; Cribbs DH; Sumbria RK
J Neuroinflammation; 2021 Dec; 18(1):312. PubMed ID: 34972522
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin-derived peptide treatment reduced neurological deficit and neuropathological changes in a mouse model of tauopathy.
Choi YB; Dunn-Meynell AA; Marchese M; Blumberg BM; Gaindh D; Dowling PC; Lu W
Alzheimers Res Ther; 2021 Jan; 13(1):32. PubMed ID: 33504364
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy.
Brody AH; Nies SH; Guan F; Smith LM; Mukherjee B; Salazar SA; Lee S; Lam TKT; Strittmatter SM
Mol Neurodegener; 2022 May; 17(1):32. PubMed ID: 35501917
[TBL] [Abstract][Full Text] [Related]
8. Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy.
Brunden KR; Zhang B; Carroll J; Yao Y; Potuzak JS; Hogan AM; Iba M; James MJ; Xie SX; Ballatore C; Smith AB; Lee VM; Trojanowski JQ
J Neurosci; 2010 Oct; 30(41):13861-6. PubMed ID: 20943926
[TBL] [Abstract][Full Text] [Related]
9. Chronic Social and Psychological Stress Impact Select Neuropathologies in the PS19 Mouse Model of Tauopathy.
Lyons CE; Graves SI; Razzoli M; Jeganathan K; Mansk RP; McGonigle S; Sabarinathan N; van Deursen JM; Baker DJ; Bartolomucci A
Psychosom Med; 2024 Jun; 86(5):366-378. PubMed ID: 37910129
[TBL] [Abstract][Full Text] [Related]
10. BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPT
Perez-Garcia G; Bicak M; Haure-Mirande JV; Perez GM; Otero-Pagan A; Gama Sosa MA; De Gasperi R; Sano M; Barlow C; Gage FH; Readhead B; Ehrlich ME; Gandy S; Elder GA
Neurosci Lett; 2023 Feb; 797():137080. PubMed ID: 36657633
[TBL] [Abstract][Full Text] [Related]
11. Dendritic Spine Remodeling and Synaptic Tau Levels in PS19 Tauopathy Mice.
Walker CK; Greathouse KM; Boros BD; Poovey EH; Clearman KR; Ramdas R; Muhammad HM; Herskowitz JH
Neuroscience; 2021 Feb; 455():195-211. PubMed ID: 33346120
[TBL] [Abstract][Full Text] [Related]
12. Focused Ultrasound-mediated Liquid Biopsy in a Tauopathy Mouse Model.
Pacia CP; Yuan J; Yue Y; Leuthardt EC; Benzinger TLS; Nazeri A; Chen H
Radiology; 2023 Apr; 307(2):e220869. PubMed ID: 36719290
[TBL] [Abstract][Full Text] [Related]
13. Long-term dantrolene treatment reduced intraneuronal amyloid in aged Alzheimer triple transgenic mice.
Wu Z; Yang B; Liu C; Liang G; Eckenhoff MF; Liu W; Pickup S; Meng Q; Tian Y; Li S; Wei H
Alzheimer Dis Assoc Disord; 2015; 29(3):184-191. PubMed ID: 25650693
[TBL] [Abstract][Full Text] [Related]
14. Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice.
Peng J; Liang G; Inan S; Wu Z; Joseph DJ; Meng Q; Peng Y; Eckenhoff MF; Wei H
Neurosci Lett; 2012 May; 516(2):274-9. PubMed ID: 22516463
[TBL] [Abstract][Full Text] [Related]
15. Intranasal administration of dantrolene increased brain concentration and duration.
Wang J; Shi Y; Yu S; Wang Y; Meng Q; Liang G; Eckenhoff MF; Wei H
PLoS One; 2020; 15(3):e0229156. PubMed ID: 32160210
[TBL] [Abstract][Full Text] [Related]
16. Tryptophan-tyrosine dipeptide improves tau-related symptoms in tauopathy mice.
Ano Y; Takaichi Y; Ohya R; Uchida K; Nakayama H; Takashima A
Nutr Neurosci; 2023 Aug; 26(8):766-777. PubMed ID: 35816407
[TBL] [Abstract][Full Text] [Related]
17. P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy.
Zhang D; Zhang W; Ming C; Gao X; Yuan H; Lin X; Mao X; Wang C; Guo X; Du Y; Shao L; Yang R; Lin Z; Wu X; Huang TY; Wang Z; Zhang YW; Xu H; Zhao Y
Neuron; 2024 May; 112(10):1676-1693.e12. PubMed ID: 38513667
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol Rescues Tau-Induced Cognitive Deficits and Neuropathology in a Mouse Model of Tauopathy.
Sun XY; Dong QX; Zhu J; Sun X; Zhang LF; Qiu M; Yu XL; Liu RT
Curr Alzheimer Res; 2019; 16(8):710-722. PubMed ID: 31368873
[TBL] [Abstract][Full Text] [Related]
19. Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury.
Parra Bravo C; Krukowski K; Barker S; Wang C; Li Y; Fan L; Vázquez-Rosa E; Shin MK; Wong MY; McCullough LD; Kitagawa RS; Choi HA; Cacace A; Sinha SC; Pieper AA; Rosi S; Chen X; Gan L
Mol Neurodegener; 2024 Jun; 19(1):51. PubMed ID: 38915105
[TBL] [Abstract][Full Text] [Related]
20. The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice.
Zhang B; Carroll J; Trojanowski JQ; Yao Y; Iba M; Potuzak JS; Hogan AM; Xie SX; Ballatore C; Smith AB; Lee VM; Brunden KR
J Neurosci; 2012 Mar; 32(11):3601-11. PubMed ID: 22423084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
